123 related articles for article (PubMed ID: 34826399)
1. Hypoxia inducible factor-3α promotes osteosarcoma progression by activating KDM3A-mediated demethylation of SOX9.
Li ZF; Meng DD; Liu YY; Bi FG; Tian K; Xu JZ; Sun JG; Gu CX; Li Y
Chem Biol Interact; 2022 Jan; 351():109759. PubMed ID: 34826399
[TBL] [Abstract][Full Text] [Related]
2. KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development.
Wang W; Wang B
BMC Cancer; 2022 May; 22(1):562. PubMed ID: 35590288
[TBL] [Abstract][Full Text] [Related]
3. Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2α.
Guo X; Tian Z; Wang X; Pan S; Huang W; Shen Y; Gui Y; Duan X; Cai Z
Acta Biochim Biophys Sin (Shanghai); 2015 Feb; 47(2):106-13. PubMed ID: 25520177
[TBL] [Abstract][Full Text] [Related]
4. KDM3A promotes oral squamous cell carcinoma cell proliferation and invasion via H3K9me2 demethylation-activated DCLK1.
Yang L; Zhang Q; Yang Q
Genes Genomics; 2022 Nov; 44(11):1333-1342. PubMed ID: 36094735
[TBL] [Abstract][Full Text] [Related]
5. The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice.
Dandawate P; Ghosh C; Palaniyandi K; Paul S; Rawal S; Pradhan R; Sayed AAA; Choudhury S; Standing D; Subramaniam D; Padhye SB; Gunewardena S; Thomas SM; Neil MO; Tawfik O; Welch DR; Jensen RA; Maliski S; Weir S; Iwakuma T; Anant S; Dhar A
Gastroenterology; 2019 Dec; 157(6):1646-1659.e11. PubMed ID: 31442435
[TBL] [Abstract][Full Text] [Related]
6. Lysine demethylase 3A in hypoxic macrophages promotes ovarian cancer development through regulation of the vascular endothelial growth factor A/Akt signaling.
Song Y; Li L; Xi Y
Tissue Cell; 2023 Dec; 85():102253. PubMed ID: 37890327
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-449a delays lung cancer development through inhibiting KDM3A/HIF-1α axis.
Hu S; Cao P; Kong K; Han P; Deng Y; Li F; Zhao B
J Transl Med; 2021 May; 19(1):224. PubMed ID: 34044859
[TBL] [Abstract][Full Text] [Related]
8. KDM3A histone demethylase functions as an essential factor for activation of JAK2-STAT3 signaling pathway.
Kim H; Kim D; Choi SA; Kim CR; Oh SK; Pyo KE; Kim J; Lee SH; Yoon JB; Zhang Y; Baek SH
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):11766-11771. PubMed ID: 30377265
[TBL] [Abstract][Full Text] [Related]
9. HIF-3α Promotes Metastatic Phenotypes in Pancreatic Cancer by Transcriptional Regulation of the RhoC-ROCK1 Signaling Pathway.
Zhou X; Guo X; Chen M; Xie C; Jiang J
Mol Cancer Res; 2018 Jan; 16(1):124-134. PubMed ID: 28928287
[TBL] [Abstract][Full Text] [Related]
10. HIF-KDM3A-MMP12 regulatory circuit ensures trophoblast plasticity and placental adaptations to hypoxia.
Chakraborty D; Cui W; Rosario GX; Scott RL; Dhakal P; Renaud SJ; Tachibana M; Rumi MA; Mason CW; Krieg AJ; Soares MJ
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7212-E7221. PubMed ID: 27807143
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of Reactive Oxygen Species in Osteosarcoma and Potential Treatment Applications.
Sun W; Wang B; Qu XL; Zheng BQ; Huang WD; Sun ZW; Wang CM; Chen Y
Cells; 2019 Dec; 9(1):. PubMed ID: 31905813
[TBL] [Abstract][Full Text] [Related]
12. HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling.
Xue X; Jungles K; Onder G; Samhoun J; Győrffy B; Hardiman KM
Oncotarget; 2016 Mar; 7(10):11567-79. PubMed ID: 26871465
[TBL] [Abstract][Full Text] [Related]
13. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
Ramadoss S; Guo G; Wang CY
Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.
Chen J; Zhang J; Yang J; Xu L; Hu Q; Xu C; Yang S; Jiang H
Atherosclerosis; 2017 Feb; 257():152-163. PubMed ID: 28135625
[TBL] [Abstract][Full Text] [Related]
15. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
Tan H; Zhao L
J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis.
Li T; Fu X; Wang J; Shang W; Wang X; Zhang L; Li J
Oncol Res; 2023; 31(3):345-359. PubMed ID: 37305393
[TBL] [Abstract][Full Text] [Related]
18. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma.
Jiang Y; Li F; Gao B; Ma M; Chen M; Wu Y; Zhang W; Sun Y; Liu S; Shen H
Theranostics; 2021; 11(8):3868-3881. PubMed ID: 33664867
[No Abstract] [Full Text] [Related]
19. KDM3A Senses Oxygen Availability to Regulate PGC-1α-Mediated Mitochondrial Biogenesis.
Qian X; Li X; Shi Z; Bai X; Xia Y; Zheng Y; Xu D; Chen F; You Y; Fang J; Hu Z; Zhou Q; Lu Z
Mol Cell; 2019 Dec; 76(6):885-895.e7. PubMed ID: 31629659
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury.
Zhao M; Wang S; Zuo A; Zhang J; Wen W; Jiang W; Chen H; Liang D; Sun J; Wang M
Cell Mol Biol Lett; 2021 Sep; 26(1):40. PubMed ID: 34479471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
